Evaluation of the effect of dexmedetomidine on hemodynamic stability and opioid requirement in patients undergoing pulmonary hydatid cyst surgery
Design
A controlled, parallel-group, double-blind, block-randomized, phase 3 clinical trial on 40 patients. Block randomization using block sizes of 4 and 6 generated via the SealedEnvelope website will be applied.
Settings and conduct
This study will be conducted at Ghaem Hospital, Mashhad. Patients aged 18–65 undergoing unilateral pulmonary hydatid cyst surgery will be enrolled after informed consent and randomized using block randomization (blocks of 4 and 6 via SealedEnvelope). The intervention group receives dexmedetomidine, and the control group receives normal saline. Hemodynamic parameters are recorded at predefined times. Patients, the assessor, and the statistician are blinded, while the administering anesthesiologist is unblinded for safety.
Participants/Inclusion and exclusion criteria
Age 18 to 65 years, Candidate for unilateral pulmonary hydatid cyst surgery (thoracotomy or VATS), ASA class I–II, Having informed consent to participate.
Intervention groups
Intervention group: Will receive dexmedetomidine intravenously as a 1 µg/kg loading dose over 10 minutes, followed by a 0.5 µg/kg/h infusion until the end of surgery.
Control group: Similar to the intervention group, an equivalent volume of Normal Saline will be infused at the same rate.
Main outcome variables
Hemodynamic stability (blood pressure and heart rate); intraoperative opioid consumption; postoperative pain score (VAS); postoperative nausea and vomiting (PONV)
General information
Reason for update
Acronym
IRCT registration information
IRCT registration number:IRCT20250626066260N1
Registration date:2025-11-21, 1404/08/30
Registration timing:prospective
Last update:2025-11-21, 1404/08/30
Update count:1
Registration date
2025-11-21, 1404/08/30
Registrant information
Name
vahid Nourbakhsh
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 930 259 8031
Email address
vhn041@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2025-12-01, 1404/09/10
Expected recruitment end date
2026-05-31, 1405/03/10
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
The Effect of Dexmedetomidine on Hemodynamic Stability and Opioid Requirement in Patients Undergoing Pulmonary Hydatid Cyst Surgery
Public title
Effect of Dexmedetomidine on Hemodynamic Stability and Opioid Requirement in Pulmonary Hydatid Cyst Surgery
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Age between 18 and 65 years
Candidate for unilateral pulmonary hydatid cyst surgery (via thoracotomy or VATS)
Physical status ASA class I or II
Written informed consent to participate in the study
Exclusion criteria:
Age
From 18 years old to 65 years old
Gender
Both
Phase
3
Groups that have been masked
Participant
Investigator
Outcome assessor
Sample size
Target sample size:
40
Randomization (investigator's opinion)
Randomized
Randomization description
In this study entitled “The Effect of Dexmedetomidine on Hemodynamic Stability and Opioid Requirement in Patients Undergoing Pulmonary Hydatid Cyst Surgery,” block randomization was used. A total of 10 random blocks with variable block sizes of 4 and 6 and different random sequences were generated using the website https://www.sealedenvelope.com/simple-randomiser/v1/lists
. The contents of each block were placed in opaque, sealed, and sequentially numbered envelopes, and all blocks were randomly arranged. As each eligible patient was enrolled, the envelope corresponding to the current block was opened sequentially, and the patient was assigned to one of the two study arms (Dexmedetomidine group or Control group) according to the sequence inside. After completion of the first block, the next block was randomly selected, and this process continued until the last block was completed and the final patient was allocated. Consequently, patients were equally distributed between the two study arms, ensuring proper balance. The unit of randomization in this study was individual, and no stratified randomization was applied. For allocation concealment, the envelopes were prepared opaque, sealed, and sequentially numbered to prevent the investigator from knowing the intervention type prior to patient enrollment. The study was designed as a double-blind trial, in which both patients and the data analyst were blinded to group allocation, while the anesthesiologist administering the drug was aware of the allocation for safety monitoring and management of potential adverse effects.
Blinding (investigator's opinion)
Double blinded
Blinding description
Participant: After receiving full information about the study protocol and providing written informed consent, participants remain unaware of their group allocation. Both dexmedetomidine and placebo solutions are prepared in identical syringes with the same volume and appearance by an independent staff member, ensuring that patients cannot distinguish their assigned intervention.
Investigator: The principal investigator does not participate in drug preparation or allocation procedures and remains blinded to group assignments throughout the data collection phase. Allocation codes are kept in sealed envelopes and will only be opened after completion of data analysis.
Outcome Assessor: The assessor responsible for recording hemodynamic variables, opioid consumption, postoperative pain scores, and clinical outcomes is fully blinded to the intervention type. The assessor works solely based on patient identification codes and has no access to information about drug assignment or administration.
Placebo
Used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Research Ethics Committees of Imam Reza Hospital Educational, Research and Treatment Center- Mashhad
Street address
Ibn Sina St., Imam Reza Hospital Square, Imam Reza Educational Research and Treatment Center
City
mashhad
Province
Razavi Khorasan
Postal code
9137913316
Approval date
2025-10-27, 1404/08/05
Ethics committee reference number
IR.MUMS.IRH.REC.1404.191
Health conditions studied
1
Description of health condition studied
Pulmonary Hydatid Cyst
ICD-10 code
B67.4
ICD-10 code description
Echinococcus granulosus infection, unspecified
Primary outcomes
1
Description
Systolic and diastolic blood pressure
Timepoint
Before induction of anesthesia; after surgical incision; every fifteen minutes during surgery; in the recovery room
Method of measurement
Measurement of systolic and diastolic blood pressure using invasive and noninvasive automatic blood pressure monitor
2
Description
Heart rate
Timepoint
Before induction of anesthesia; after surgical incision; every fifteen minutes during surgery; in the recovery room
Method of measurement
Measurement of heart rate using an electrocardiographic cardiac monitor
3
Description
Total intraoperative opioid consumption
Timepoint
From the beginning of anesthesia induction until the end of the surgical procedure
Method of measurement
Calculation of the total opioid dose based on values recorded by the anesthesia team in the anesthesia record
Secondary outcomes
1
Description
Postoperative pain score measured by the Visual Analogue Scale
Timepoint
In the recovery room; two hours after surgery; four hours after surgery
Method of measurement
Measurement using a ten-centimeter Visual Analogue Scale for pain assessment
2
Description
Postoperative nausea and vomiting
Timepoint
In the recovery room; two hours after surgery; four hours after surgery
Method of measurement
Clinical observation and documentation of nausea and vomiting events by the recovery room nurse
3
Description
Sedation level assessed by the Ramsay Sedation Scale
Timepoint
In the recovery room; thirty minutes after admission to recovery
Method of measurement
Assessment using the Ramsay Sedation Scale
Intervention groups
1
Description
Intervention group: Includes patients who, after induction of anesthesia, receive dexmedetomidine initially at a dose of 1 µg/kg over 10 minutes, followed by 0.5 µg/kg/h via intravenous infusion until the end of surgery.
Category
Treatment - Drugs
2
Description
Control group: Includes patients who, under the same anesthetic conditions, receive an equivalent volume of normal saline instead of dexmedetomidine at the same infusion rate (placebo). Other anesthetic management and therapeutic interventions are the same as in the intervention group.
Category
Placebo
Recruitment centers
1
Recruitment center
Name of recruitment center
Ghaem hospital
Full name of responsible person
Vahid Nourbakhsh
Street address
Ahmadabad Street, Qaem Hospital
City
mashhad
Province
Razavi Khorasan
Postal code
9176699199
Phone
+98 915 834 0408
Fax
Email
vhn041@gmail.com
Web page address
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Mohsen Tafaqodi
Street address
Daneshgah Street - next to Howezeh Cinema - Qureshi Building - Research and Technology Vice-Chancellor
City
mashhad
Province
Razavi Khorasan
Postal code
9138813944
Phone
+98 51 3841 1538
Email
vcresearch@mums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Mashhad University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Vahid Nourbakhsh
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Anesthesiology
Street address
Ahmadabad Street, Qaem Hospital
City
mashhad
Province
Razavi Khorasan
Postal code
9176699199
Phone
+98 915 834 0408
Fax
Email
vhn041@gmail.com
Web page address
Person responsible for scientific inquiries
Contact
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Alireza Sharifian Attar
Position
Professor
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Ahmadabad Street, Qaem Hospital
City
mashhad
Province
Razavi Khorasan
Postal code
9176699199
Phone
009153150596
Fax
Email
sharifiana@mums.ac.ir
Web page address
Person responsible for updating data
Contact
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Vahid Nourbakhsh
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Anesthesiology
Street address
Ahmadabad Street, Qaem Hospital
City
mashhad
Province
Razavi Khorasan
Postal code
9176699199
Phone
+98 915 834 0408
Fax
Email
vhn041@gmail.com
Web page address
Sharing plan
Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available